The emerging role of enhanced external counterpulsation in cardiovascular disease management

Cardiovascular Reviews and Reports

Volumn 18, Issue 11, 1997, Pages 20-25

  Strobeck, John E ^a,b   Baklajian, Robert ^a   Hannan, Joseph C ^a  

^a Heart Lung Center   (United States)

^b Heart Lung Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; DILTIAZEM; GLIBENCLAMIDE; ISOSORBIDE 5 NITRATE; ISOSORBIDE DINITRATE; METOPROLOL; NIFEDIPINE; PROPRANOLOL; WARFARIN;

ADULT; AGED; ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CASE REPORT; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COUNTERPULSATION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030666164     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Knatterud GL, Bourassa MG, Pepine CJ, et al. Effects of treatment strategies to supress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study./ Am Coll Cardiol. 1994:24:11-20.
2. Rogers WJ, Bourassa MG, Andrews TC, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization.y/lm Coll Cardiol. 1995:26:594-605.
3. Stevens NG, Parsons A, Schofield PM, et al. Randomized controlled trial of vitamin E in patients with coronary artery disease: Cambridge Heart Anti-Oxidant Study (CHAOS). Lancet. 1996;347:781-786.
4. Suresh K, Simandl S, Lawson WE, et al. Maximizing the hemodynamic benefit of enhanced external counterpulsation. Poster #40, Biomedicine 1997;April 25-27, 1997, Washington, DC.
5. Lawson WE, Hui JCK, Oster ZH, et al. Enhanced external counterpulsation as an adjunct to revascularization in unstable angina. Clin Cardiol. 1997:20:178-180.